Andrea Venturelli

President of NGU Holding

📍 Brescia, Lombardy, Italy🔄 Updated September 2026💼 5 investments📅 17 years investing🗓 Last invested Jan 2024
VC🌍 Italy
5
Total investments
2
Early stage
1
Mid stage
0
Late stage
17y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2024
The Recross Septal Occluder preserves future access to the left heart using a patented polymer skin
Board Member
Dec 2020
Arcadia aims to bring innovative brands, organizations, artists and activists together to showcase the best of the environmental movement and foster engaged conversation. With immersive art experiences, community engagement projects and a solutions-driven marketplace, we provide an otherworldly platform to raise awareness about sustainability and circular design.
early stageDesign
Board Member
Sep 2015
Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector: • 100 % automatic • 100 % safe • 100 % digital • 100 % user friendly More info at www.angiodroid.com
Experience · 7 entries
All (7)
Investments (5)
Founder (1)
Board (5)
2024
Board Member
Jan 2024
The Recross Septal Occluder preserves future access to the left heart using a patented polymer skin
2020
Board Member
Dec 2020
Arcadia aims to bring innovative brands, organizations, artists and activists together to showcase the best of the environmental movement and foster engaged conversation. With immersive art experiences, community engagement projects and a solutions-driven marketplace, we provide an otherworldly platform to raise awareness about sustainability and circular design.
early stageDesign
2019
Board Member
Oct 2019
Green School Bali is an international, progressive Pre-Kindergarten to Grade 12 school located in the heart of the jungle in Bali, Indonesia founded in 2008 by former jewelry designers, John and Cynthia Hardy. The school currently has 41 nationalities in its 500-strong student body and receives no government funding with 42 Local Balinese scholars on full-scholarships and an additional 470 Balinese students who come to Green School after their normal school day to learn English and sustainability in the 'Trash for Class'​ program as part of Green School's 'Kul Kul Connection'​ community integration program. Green School's mission is a 'Community of learners making our world sustainable'​ and is so much more than a school - it is a community where all members - students, staff, parents, volunteers and the surrounding community - come to learn and engage in various social enterprises, such as Green School's innovation hub (makers space), Kembali (Green School's resource management centre) to help build and educate on sustainable solutions for the future. Green School's tailor-made campus includes beautiful wall-less bamboo classrooms, specifically designed to encourage play, creativity, collaboration and facilitate learning. Green School is accredited by WASC (Western Association of Schools and Colleges).
2015
Board Member
Sep 2015
Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector: • 100 % automatic • 100 % safe • 100 % digital • 100 % user friendly More info at www.angiodroid.com
2013
Venture Partner
Jan 2013
We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside its partners through its offices in Turin, Milan and San Francisco. Our mission is to generate high-level returns for our investors by turning entrepreneurship and technology into fast-growing and successful companies.
Show all 7 entries ↓
Investment activity
2009–2024 · 5 investments
2009120151201912020120241
Recent (last 2 years)Earlier